Baolingbao Biology Co Ltd (002286) — Strategic Asset Allocation Index
Baolingbao Biology Co Ltd (002286) has a Strategic Asset Allocation Index of 72.1% as of September 2023. Strategic assets (PP&E of CN¥1.44 Billion plus long-term investments of CN¥-) total CN¥1.44 Billion, measured against net assets of CN¥2.00 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 002286 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Baolingbao Biology Co Ltd Strategic Asset Allocation Index (2006–2022)
This chart shows how Baolingbao Biology Co Ltd's Strategic Asset Allocation Index has evolved across 17 annual periods from 2006 to 2022. As of September 2023, the index stands at 72.1%, representing strategic assets of CN¥1.44 Billion against net assets of CN¥2.00 Billion CNY. See Baolingbao Biology Co Ltd (002286) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Baolingbao Biology Co Ltd (2006–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Baolingbao Biology Co Ltd from 2006 to 2022, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 002286 market cap.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 76.4% | CN¥1.53 Billion | CN¥1.53 Billion | CN¥- | CN¥2.00 Billion | ▲ +5.5 pp |
| 2021 | 70.9% | CN¥1.29 Billion | CN¥1.29 Billion | CN¥- | CN¥1.81 Billion | ▼ -5.6 pp |
| 2020 | 76.6% | CN¥1.22 Billion | CN¥1.22 Billion | CN¥- | CN¥1.60 Billion | ▲ +1.4 pp |
| 2019 | 75.1% | CN¥1.18 Billion | CN¥1.18 Billion | CN¥- | CN¥1.57 Billion | ▼ -19.4 pp |
| 2018 | 94.5% | CN¥1.46 Billion | CN¥1.20 Billion | CN¥256.20 Million | CN¥1.54 Billion | ▲ +15.6 pp |
| 2017 | 78.9% | CN¥1.20 Billion | CN¥1.12 Billion | CN¥87.15 Million | CN¥1.53 Billion | ▲ +2.0 pp |
| 2016 | 76.9% | CN¥1.16 Billion | CN¥1.07 Billion | CN¥86.45 Million | CN¥1.51 Billion | ▼ -0.1 pp |
| 2015 | 77.0% | CN¥1.14 Billion | CN¥1.07 Billion | CN¥67.84 Million | CN¥1.48 Billion | ▲ +13.2 pp |
| 2014 | 63.8% | CN¥924.31 Million | CN¥924.31 Million | CN¥- | CN¥1.45 Billion | ▲ +7.0 pp |
| 2013 | 56.7% | CN¥814.33 Million | CN¥814.33 Million | CN¥- | CN¥1.44 Billion | ▼ -31.3 pp |
| 2012 | 88.1% | CN¥719.99 Million | CN¥719.99 Million | CN¥- | CN¥817.45 Million | ▼ -4.5 pp |
| 2011 | 92.6% | CN¥704.18 Million | CN¥704.18 Million | CN¥- | CN¥760.53 Million | ▲ +5.2 pp |
| 2010 | 87.3% | CN¥614.16 Million | CN¥614.16 Million | CN¥- | CN¥703.11 Million | ▲ +6.2 pp |
| 2009 | 81.2% | CN¥537.74 Million | CN¥537.74 Million | CN¥- | CN¥662.61 Million | ▼ -94.4 pp |
| 2008 | 175.6% | CN¥418.02 Million | CN¥418.02 Million | CN¥- | CN¥238.05 Million | ▼ -13.2 pp |
| 2007 | 188.8% | CN¥364.93 Million | CN¥364.93 Million | CN¥- | CN¥193.28 Million | ▲ +24.2 pp |
| 2006 | 164.6% | CN¥185.20 Million | CN¥185.20 Million | CN¥- | CN¥112.53 Million | — |